FindTrial
Sign In

Clinical study on the effect of Sansang Shenqi Decoction on airway function in patients with chronic obstructive pulmonary disease at stable period

Clinical study on the effect of Sansang Shenqi Decoction on airway function in patients with chronic obstructive pulmonary disease at stable period

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036980
Enrollment
Unknown
Registered
2020-08-26
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

experimental group:Sansang Shenqi Decoction+Symbicort Turbuhaler
control group:Symbicort Turbuhaler

Sponsors

LongHua Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.COPD in stable phase; 2.Syndrome differentiation of traditional Chinese medicine is kidney deficiency; 3.40 years old <= age <= 75 years old, regardless of gender; 4.Informed consent, sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Chronic cough wheezing caused by tuberculosis, fungus, tumor, silicosis, irritant gas, allergy and other factors; 2.Severe cardiopulmonary insufficiency; 3.Complicated with cardiovascular, renal, lung, hematopoietic system and other serious primary diseases and psychosis; 4.A pregnant or lactating woman; 5.Allergic constitution or allergic to multiple drugs.

Design outcomes

Primary

MeasureTime frame
FEV1%;—

Secondary

MeasureTime frame
TNF-a;TGF-ß1;IL-2;IL-8;—

Countries

China

Contacts

Public ContactShiying An

LongHua Hospital Shanghai University of Traditional Chinese Medicine

anshiyingtcm@126.com+86 13661958350

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026